| Patent application number | Description | Published |
|---|
| 20080293730 | Tricyclo Substituted Amides - Compounds of Formula (I): (formula) or pharmaceutically acceptable salts thereof, are useful in the prophylactic and therapeutic treatment of hyperglycemia and diabetes. | 11-27-2008 |
| 20080293741 | Tricyclo Substituted Amides as Glucokinase Modulators - Compounds of Formula (I): (I) or pharmaceutically acceptable salts thereof, are useful in the prophylactic and therapeutic treatment of hyperglycemia and diabetes. | 11-27-2008 |
| 20090005391 | Tricyclo Substituted Amides - Compounds of Formula (I) or pharmaceutically acceptable salts thereof, are useful in the prophylactic and therapeutic treatment of hyperglycemia and diabetes. | 01-01-2009 |
| 20090054444 | SUBSTITUTED PHENYLACETAMIDES AND THEIR USE AS GLUCOKINASE ACTIVATORS - Compounds of Formula (I) wherein R | 02-26-2009 |
| 20090221824 | ENANTIOSELECTIVE PROCESS - A process for the production of compounds comprising the enantioselective hydrogenation of 2-substituted acrylic acid derivatives. | 09-03-2009 |
| 20100022591 | PIPERIDINE GPCR AGONISTS - Compounds of formula (I): or pharmaceutically acceptable salts thereof, are GPCR agonists and are useful as for the treatment of obesity and diabetes. | 01-28-2010 |
| 20100048631 | Piperidine GPCR Agonists - Compounds of formula (I): or pharmaceutically acceptable salts thereof, are GPCR agonists and are useful as for the treatment of obesity and diabetes. | 02-25-2010 |
| 20100105732 | PIPERIDINE GPCR AGONISTS - Compounds of formula (I): or pharmaceutically acceptable salts thereof, are GPCR agonists and are useful as for the treatment of obesity and diabetes. | 04-29-2010 |
| 20100286110 | AZETIDINYL G-PROTEIN COUPLED RECEPTOR AGONISTS - Compounds of formula (I) or pharmaceutically acceptable salts thereof, are agonists of GPR119 and are useful for the treatment of diabetes and as peripheral regulators of satiety, e.g. for the treatment of obesity and metabolic syndrome. | 11-11-2010 |
| 20100286112 | COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS - The present invention is directed to therapeutic compounds which have dual activity as agonists of GPR119 and inhibitors of DPP-IV and are useful for the treatment of metabolic disorders including type II diabetes. | 11-11-2010 |
